Skip to content

Vivani Medical, Inc.: 10-Q filed 2015-08-05

What Vivani Medical, Inc. reported in its quarterly report filed 2015-08-05 (fiscal Q2 2015): 35 published measures, 92 facts as tagged in accession 0001615774-15-002074.

This filing

Form
10-Q (quarterly report)
Filed
2015-08-05
Fiscal period
fiscal Q2 2015
Accession
0001615774-15-002074 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Vivani Medical, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2015-06-3036,941,334USD
At 2014-12-3143,069,444USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2015-06-3028,100,852USD
At 2014-12-3134,618,247USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2015-06-30407,439USD
At 2014-12-31619,411USD
At 2014-06-302,946,729USD
At 2013-12-3162,565USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-4,922,375USD91
2015-01-01 to 2015-06-30-9,878,712USD181
2014-04-01 to 2014-06-30-7,541,075USD91
2014-01-01 to 2014-06-30-13,979,828USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2015-01-01 to 2015-06-30291,726USD181
2014-01-01 to 2014-06-30281,033USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2015-04-01 to 2015-06-302,661,099USD91
2015-01-01 to 2015-06-304,361,181USD181
2014-04-01 to 2014-06-30611,477USD91
2014-01-01 to 2014-06-301,268,203USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2015-01-01 to 2015-06-302,155,264USD181
2014-01-01 to 2014-06-307,987,808USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2015-01-01 to 2015-06-307,528,036USD181
2014-01-01 to 2014-06-305,251,076USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2015-06-30-162,542,680USD
At 2014-12-31-152,663,968USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2015-06-301,138,218USD
At 2014-12-311,004,646USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2015-04-01 to 2015-06-30564,149USD91
2015-01-01 to 2015-06-301,061,328USD181
2014-04-01 to 2014-06-30227,953USD91
2014-01-01 to 2014-06-30823,764USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-4,947,493USD91
2015-01-01 to 2015-06-30-9,908,271USD181
2014-04-01 to 2014-06-30-5,562,876USD91
2014-01-01 to 2014-06-30-10,019,361USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2015-06-3035,745,615USD
At 2014-12-3141,976,188USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2015-06-308,840,482USD
At 2014-12-318,451,197USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2015-06-30330,379USD
At 2014-12-31513,106USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2015-06-301,208,832USD
At 2014-12-31707,648USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2015-04-01 to 2015-06-306,039,206USD91
2015-01-01 to 2015-06-3011,404,313USD181
2014-04-01 to 2014-06-305,181,299USD91
2014-01-01 to 2014-06-309,567,077USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2015-06-306,805,011USD
At 2014-12-315,721,991USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,091,713USD91
2015-01-01 to 2015-06-301,496,042USD181
2014-04-01 to 2014-06-30-381,577USD91
2014-01-01 to 2014-06-30-452,284USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2015-04-01 to 2015-06-301,569,386USD91
2015-01-01 to 2015-06-302,865,139USD181
2014-04-01 to 2014-06-30993,054USD91
2014-01-01 to 2014-06-301,720,487USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2015-04-01 to 2015-06-30848,764USD91
2015-01-01 to 2015-06-301,896,621USD181
2014-04-01 to 2014-06-301,220,189USD91
2014-01-01 to 2014-06-302,259,675USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2015-06-3035,819,332shares
At 2014-12-3135,241,428shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2015-06-3025,651,696USD
At 2014-12-3124,590,368USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2015-06-30-476,580USD
At 2014-12-31-473,972USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2015-06-305,637,478USD
At 2014-12-315,484,165USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2015-06-304,499,260USD
At 2014-12-314,479,519USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2015-06-301,916,858USD
At 2014-12-311,412,383USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2015-06-301,144,532USD
At 2014-12-31927,575USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2015-04-01 to 2015-06-30-4,865,783USD91
2015-01-01 to 2015-06-30-9,881,320USD181
2014-04-01 to 2014-06-30-7,571,636USD91
2014-01-01 to 2014-06-30-14,056,068USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2015-04-01 to 2015-06-302,000,105USD91
2015-01-01 to 2015-06-303,655,921USD181
2014-04-01 to 2014-06-301,420,051USD91
2014-01-01 to 2014-06-302,917,178USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2015-01-01 to 2015-06-30158,154USD181
2014-01-01 to 2014-06-30144,503USD181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2015-01-01 to 2015-06-300USD181
2014-01-01 to 2014-06-307,578,977USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30501,184USD181
2014-01-01 to 2014-06-30-9,237USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-301,083,020USD181
2014-01-01 to 2014-06-301,694,066USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2015-01-01 to 2015-06-30-182,727USD181
2014-01-01 to 2014-06-30386,372USD181

Inspect the source

Entity
Vivani Medical, Inc. / CIK 0001266806
Captured
2026-09-20T07:47:29.230Z
SEC response SHA-256
15463ebc11bbf3e9f4496bfc06a4c02394ee50679da394698e4aa269147e217a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001266806.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))